Chalid Assaf

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Rein Willemze, Patty M. Jansen, Lorenzo Cerroni et al. · Blood · 2007 · 689 citations

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +9

Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules

HD Foss, Ioannis Anagnostopoulos, Iguaracyra Araújo et al. · Blood · 1996 · 233 citations · Full text

Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma

H. Miles Prince, Madeleine Duvic, Ann Martin et al. · Journal of Clinical Oncology · 2010 · 231 citations

Immunology, Denileukin Diftitox, Pathology +17

Guidelines on the use of extracorporeal photopheresis

Robert Knobler, Gösta Berlin, Piergiacomo Calzavara‐Pinton et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 217 citations · Full text